Bain Capital Private Equity
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Bain Capital Private Equity is a private equity firm that focuses on a value-added investment approach.
Investor Profile
Bain Capital Private Equity has made 22 investments, with 1 in the past 12 months and 36% as lead.
Stage Focus
- Private Equity (55%)
- Post Ipo Equity (14%)
- Series B (9%)
- Secondary Market (5%)
- Series A (5%)
- Series C (5%)
- Post Ipo Debt (5%)
- Series E (5%)
Country Focus
- United States (59%)
- China (14%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
- Japan (9%)
- Singapore (5%)
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
- Switzerland (5%)
- Italy (5%)
- Germany (5%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Pharmaceutical
- Software
- Medical Device
- Hospital
- Manufacturing
- Consumer
- Consulting
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
